The interventional therapy for diabetic peripheral artery disease
BMC Surgery
|August 21, 2013
Summary
Balloon angioplasty (PTA) is a safe and effective treatment for diabetic peripheral artery disease, significantly improving blood flow and reducing amputation risk. This intervention shows promising short-term results for patients with diabetes.
Area of Science:
- Vascular Surgery
- Diabetology
- Interventional Cardiology
Background:
- Diabetic peripheral arterial disease is a leading cause of lower limb amputation.
- Effective interventions are crucial to prevent amputation in diabetic patients.
Purpose of the Study:
- To evaluate the clinical effectiveness of balloon angioplasty (PTA) for treating diabetic peripheral artery disease.
- To summarize the technique and clinical experiences of PTA in this patient population.
Main Methods:
- 81 patients with diabetic peripheral artery disease underwent balloon PTA.
- The procedure involved Seldinger puncture, catheterization, and balloon angioplasty (4-6mm diameter, 6-10 atm pressure).
Main Results:
- 100% technical success rate with no complications.
- Significant improvements in skin temperature, blood supply, and arterial pulsation.
- Reduced numbness and pain, improved vessel diameter, and enhanced foot ulcer healing.
- No amputations were performed; short-term outcomes were satisfactory.
Conclusions:
- Balloon angioplasty (PTA) is a feasible and clinically significant technique for diabetic peripheral artery disease.
- The procedure demonstrates satisfactory short-term efficacy.
- Long-term follow-up is necessary to fully assess the durability of the results.
Related Concept Videos
01:27Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
01:27Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
01:26Peripheral Artery Disease IV: Nursing Management
The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses, temperature changes,...
01:21Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:30Peripheral Artery Disease I: Introduction
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...